Elevance Health - ELV Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $570.60
Forecasted Upside: 21.33%
Number of Analysts: 12
Breakdown:
0 Sell Ratings
1 Hold Ratings
11 Buy Ratings
0 Strong Buy Ratings

^$470.27 As of 06/9/2023 01:00 AM ET

▲ +4.01 (0.86%)

1 month | 3 months | 12 months

Get New Elevance Health Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for ELV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ELV

^$570.60

▲ +21.33% Upside Potential

This price target is based on 12 analysts offering 12 month price targets for Elevance Health in the last 3 months. The average price target is $570.60, with a high forecast of $610.00 and a low forecast of $547.00. The average price target represents a 21.33% upside from the last price of $470.27.

Current Consensus is Buy

The current consensus among 12 investment analysts is to buy stock in Elevance Health. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
17 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

12/16/2021

0 strong buy ratings
17 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

3/16/2022

0 strong buy ratings
19 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

6/14/2022

0 strong buy ratings
18 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

9/12/2022

0 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

12/11/2022

0 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

3/11/2023

0 strong buy ratings
12 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

5/10/2023

0 strong buy ratings
11 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

6/9/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/27/2023	22nd Century Group	Reiterated Rating	Upgrade		Low
4/27/2023	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$500.00 ➝ $571.00	Low
4/24/2023	Wells Fargo & Company	Lower Target		$597.00 ➝ $561.00	Low
4/21/2023	Loop Capital	Lower Target	Buy	$565.00 ➝ $550.00	Low
4/20/2023	Cantor Fitzgerald	Initiated Coverage	Overweight	$547.00	Low
4/20/2023	Deutsche Bank Aktiengesellschaft	Boost Target		$571.00 ➝ $575.00	Low
4/20/2023	TD Cowen	Lower Target	Outperform	$577.00 ➝ $564.00	Low
3/28/2023	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$523.00 ➝ $572.00	Low
3/24/2023	Truist Financial	Lower Target	Buy	$610.00 ➝ $580.00	Low
3/21/2023	Wells Fargo & Company	Lower Target	Equal Weight	$609.00 ➝ $597.00	Low
3/8/2023	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$581.00 ➝ $571.00	Low
2/23/2023	JPMorgan Chase & Co.	Boost Target	Overweight	$555.00 ➝ $572.00	Low
1/30/2023	Loop Capital	Boost Target		$550.00 ➝ $565.00	Low
1/26/2023	Royal Bank of Canada	Boost Target	Sector Perform	$505.00 ➝ $523.00	Low
1/26/2023	SVB Leerink	Reiterated Rating	Outperform	$580.00	Low
1/4/2023	Wells Fargo & Company	Boost Target	Overweight	$557.00 ➝ $609.00	Low
11/10/2022	Mizuho	Boost Target	Buy	$545.00 ➝ $575.00	Low
10/24/2022	UBS Group	Boost Target		$585.00 ➝ $610.00	Low
10/21/2022	Morgan Stanley	Boost Target	Equal Weight	$485.00 ➝ $500.00	Low
10/21/2022	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$576.00 ➝ $581.00	Low
9/9/2022	Bank of America	Upgrade	Neutral ➝ Buy	$535.00 ➝ $575.00	Low
8/22/2022	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$490.00 ➝ $580.00	Low
7/25/2022	Morgan Stanley	Lower Target	Equal Weight	$533.00 ➝ $485.00	Low
7/22/2022	Stephens	Lower Target		$550.00	Low
7/22/2022	Cowen	Lower Target		$577.00	Low
7/22/2022	SVB Leerink	Lower Target	Market Perform ➝ Market Perform	$555.00 ➝ $490.00	Low
7/21/2022	Royal Bank of Canada	Lower Target		$544.00 ➝ $505.00	Low
6/22/2022	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$607.00 ➝ $533.00	Low
6/16/2022	Loop Capital	Initiated Coverage	Buy	$550.00	High
5/26/2022	Sanford C. Bernstein	Initiated Coverage	Outperform	$577.00 ➝ $596.00	Medium
5/25/2022	Wells Fargo & Company	Lower Target	Overweight	$586.00 ➝ $580.00	Low
5/4/2022	Mizuho	Boost Target		$510.00 ➝ $545.00	High
4/25/2022	BMO Capital Markets	Boost Target	Outperform	$540.00 ➝ $625.00	Medium
4/22/2022	Wells Fargo & Company	Set Target	Overweight	$460.00 ➝ $586.00	High
4/22/2022	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$453.00 ➝ $574.00	High
4/21/2022	Cowen	Boost Target		$472.00 ➝ $642.00	Medium
4/21/2022	Jefferies Financial Group	Boost Target		$575.00 ➝ $625.00	Low
4/21/2022	Truist Financial	Boost Target		$590.00 ➝ $610.00	High
4/21/2022	Cowen	Boost Target		$472.00 ➝ $642.00	High
4/21/2022	Morgan Stanley	Boost Target	Overweight	$518.00 ➝ $607.00	High
4/21/2022	SVB Leerink	Boost Target	Market Perform	$483.00 ➝ $555.00	Medium
4/21/2022	The Goldman Sachs Group	Boost Target	Buy	$527.00 ➝ $605.00	Medium
4/21/2022	Credit Suisse Group	Boost Target	Outperform	$518.00 ➝ $584.00	High
4/7/2022	Truist Financial	Boost Target		$540.00 ➝ $590.00	Medium
3/29/2022	Jefferies Financial Group	Reiterated Rating	Buy ➝ Buy	$559.00	Low
3/29/2022	UBS Group	Boost Target	Buy	$477.00 ➝ $541.00	High
3/15/2022	SVB Leerink	Boost Target	Market Perform	$465.00 ➝ $483.00	Medium
2/7/2022	Argus	Boost Target	Buy	$475.00 ➝ $500.00	Medium
1/28/2022	Morgan Stanley	Lower Target	Overweight	$561.00 ➝ $518.00	Low
1/27/2022	SVB Leerink	Boost Target	Market Perform	$430.00 ➝ $465.00	Medium
1/11/2022	Sanford C. Bernstein	Boost Target		$559.00 ➝ $574.00	Medium
1/5/2022	Truist Financial	Boost Target	Buy ➝ Buy	$490.00 ➝ $540.00	Medium
12/20/2021	Mizuho	Upgrade	Neutral ➝ Buy	$450.00 ➝ $510.00	Medium
12/17/2021	Morgan Stanley	Boost Target	Overweight	$486.00 ➝ $561.00	Medium
12/14/2021	The Goldman Sachs Group	Initiated Coverage	Conviction-Buy	$517.00	Low
10/29/2021	Mizuho	Boost Target	Neutral	$385.00 ➝ $450.00	Low
10/25/2021	Argus	Boost Target	Buy	$435.00 ➝ $475.00	Low
10/25/2021	Wells Fargo & Company	Boost Target	Overweight	$460.00 ➝ $500.00	Low
10/22/2021	BMO Capital Markets	Boost Target	Outperform	$465.00 ➝ $500.00	Low
10/22/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$408.00 ➝ $460.00	Low
10/21/2021	Truist Financial	Boost Target	Buy	$450.00 ➝ $490.00	High
10/21/2021	Morgan Stanley	Boost Target	Overweight	$468.00 ➝ $486.00	High
10/21/2021	SVB Leerink	Boost Target	Market Perform	$403.00 ➝ $430.00	High
10/21/2021	Credit Suisse Group	Boost Target	Outperform	$425.00 ➝ $486.00	High
10/21/2021	Royal Bank of Canada	Boost Target	Sector Perform	$408.00 ➝ $452.00	High
10/21/2021	Stephens	Boost Target	Overweight	$440.00 ➝ $475.00	High
10/21/2021	Barclays	Boost Target	Overweight	$450.00 ➝ $485.00	High
10/21/2021	Citigroup	Boost Target	Buy	$445.00 ➝ $497.00	High
9/27/2021	SVB Leerink	Initiated Coverage	Market Perform	$403.00	High
9/9/2021	Cowen	Initiated Coverage	Outperform	$465.00	High
8/31/2021	Morgan Stanley	Boost Target	Overweight	$459.00 ➝ $468.00	High
7/22/2021	Jefferies Financial Group	Boost Target	Buy	$447.00 ➝ $453.00	Low
7/22/2021	Stephens	Boost Target	Overweight	$430.00 ➝ $440.00	Low
7/22/2021	BMO Capital Markets	Boost Target	Outperform	$450.00 ➝ $465.00	Low
7/22/2021	Barclays	Boost Target	Overweight	$425.00 ➝ $450.00	Low
7/22/2021	Cantor Fitzgerald	Boost Target	Overweight	$430.00 ➝ $455.00	Low
7/22/2021	Mizuho	Boost Target	Neutral	$380.00 ➝ $385.00	Low
7/22/2021	Royal Bank of Canada	Boost Target	Sector Perform	$399.00 ➝ $408.00	Low
7/9/2021	Seaport Res Ptn	Reiterated Rating	Buy		Low
7/2/2021	Morgan Stanley	Boost Target	Overweight	$454.00 ➝ $459.00	Medium
6/10/2021	Royal Bank of Canada	Downgrade	Outperform ➝ Sector Perform	$399.00	Low
5/24/2021	Wells Fargo & Company	Initiated Coverage	Overweight	$460.00	N/A
5/18/2021	Wells Fargo & Company	Initiated Coverage	Overweight	$460.00	Low
5/6/2021	Argus	Boost Target	Average ➝ Buy	$330.00 ➝ $435.00	Low
5/3/2021	Mizuho	Boost Target	Neutral	$320.00 ➝ $380.00	Medium
4/22/2021	Truist Financial	Boost Target		$425.00 ➝ $450.00	Low
4/22/2021	Stephens	Boost Target	Overweight	$395.00 ➝ $430.00	Low
4/22/2021	BMO Capital Markets	Boost Target	Outperform	$440.00 ➝ $450.00	Low
4/22/2021	Royal Bank of Canada	Boost Target	Outperform	$350.00 ➝ $399.00	Low
4/22/2021	Barclays	Boost Target	Overweight	$375.00 ➝ $425.00	Low
4/20/2021	Truist Financial	Boost Target	Buy	$425.00 ➝ $450.00	Low
4/14/2021	Truist Financial	Boost Target		$375.00 ➝ $425.00	High
4/14/2021	Cowen	Boost Target	Outperform	$360.00 ➝ $395.00	Low
3/9/2021	Truist Financial	Upgrade	Hold ➝ Buy	$360.00 ➝ $375.00	Low
3/4/2021	Truist Financial	Upgrade	Hold ➝ Buy	$360.00 ➝ $375.00	High
1/28/2021	Credit Suisse Group	Lower Target	Outperform	$389.00 ➝ $382.00	High
1/28/2021	Stephens	Lower Target	Overweight	$350.00 ➝ $340.00	High
1/26/2021	Cowen	Boost Target	Outperform	$330.00 ➝ $360.00	Medium
1/15/2021	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$305.00 ➝ $402.00	Medium
1/13/2021	Argus	Boost Target	Outperform ➝ Buy	$300.00 ➝ $380.00	Low
1/5/2021	Truist Financial	Boost Target		$320.00 ➝ $360.00	N/A
12/18/2020	Mizuho	Boost Target	Neutral	$300.00 ➝ $320.00	High
12/14/2020	SVB Leerink	Boost Target	Outperform	$370.00 ➝ $400.00	Low
11/11/2020	Piper Sandler	Boost Target	Overweight	$330.00 ➝ $369.00	High
11/6/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$324.00 ➝ $389.00	Low
10/29/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$349.00 ➝ $337.00	Medium
10/29/2020	Smith Barney Citigroup	Boost Target		$325.00 ➝ $338.00	Medium
10/29/2020	SVB Leerink	Boost Target	Outperform	$345.00 ➝ $370.00	High
7/30/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$362.00 ➝ $349.00	Low
7/30/2020	Royal Bank of Canada	Boost Target	Outperform	$319.00 ➝ $331.00	Medium
7/30/2020	SVB Leerink	Boost Target	Outperform	$325.00 ➝ $345.00	Low
7/10/2020	Jefferies Financial Group	Boost Target	Hold	$271.00 ➝ $281.00	Low
7/1/2020	SVB Leerink	Initiated Coverage	Outperform	$325.00	Medium
6/9/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$360.00	Medium
6/5/2020	The Goldman Sachs Group	Initiated Coverage	Neutral	$340.00	High
5/21/2020	SunTrust Banks	Boost Target	Hold	$280.00 ➝ $320.00	Low
5/12/2020	UBS Group	Boost Target	Buy	$307.00 ➝ $330.00	Low
4/30/2020	Morgan Stanley	Boost Target	Overweight	$310.00 ➝ $423.00	High
4/29/2020	Cfra	Upgrade	Hold ➝ Buy	$290.00 ➝ $306.00	Medium
4/13/2020	Morgan Stanley	Boost Target	Overweight	$291.00 ➝ $310.00	Low
4/13/2020	SunTrust Banks	Lower Target	Hold	$330.00 ➝ $280.00	Low
4/12/2020	Royal Bank of Canada	Reiterated Rating	Buy	$319.00	Low
4/9/2020	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$257.00	Medium
3/27/2020	Morgan Stanley	Lower Target	Buy	$374.00 ➝ $291.00	Low
2/18/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$314.00 ➝ $362.00	Medium
1/31/2020	Morgan Stanley	Lower Target	Overweight	$382.00 ➝ $374.00	Low
1/31/2020	Credit Suisse Group	Lower Target	Outperform	$380.00 ➝ $355.00	Low
1/31/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$319.00 ➝ $314.00	Low
1/30/2020	Bank of America	Lower Target	Neutral	$330.00 ➝ $324.00	Medium
1/29/2020	Stephens	Lower Target	Overweight	$345.00 ➝ $330.00	High
1/8/2020	Credit Suisse Group	Boost Target	Outperform	$340.00 ➝ $380.00	Medium
1/3/2020	Evercore ISI	Upgrade	In-Line ➝ Outperform		Medium
12/20/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$322.00 ➝ $391.00	Medium
12/6/2019	Bank of America	Downgrade	Buy ➝ Neutral		Low
10/24/2019	Credit Suisse Group	Lower Target	Outperform	$345.00 ➝ $340.00	Low
10/17/2019	Mizuho	Initiated Coverage	Neutral	$262.00	Low
9/26/2019	Morgan Stanley	Lower Target	Overweight	$371.00 ➝ $356.00	Low
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy		Low
7/26/2019	Wells Fargo & Company	Reiterated Rating	Buy		N/A
7/12/2019	Morgan Stanley	Boost Target	Overweight	$359.00 ➝ $371.00	Low
5/10/2019	Citigroup	Upgrade	Neutral ➝ Buy	$325.00	Low
4/25/2019	Barclays	Boost Target	Overweight ➝ Overweight	$316.00 ➝ $317.00	Medium
4/25/2019	Morgan Stanley	Lower Target	Overweight ➝ Overweight	$391.00 ➝ $359.00	Medium
4/25/2019	SunTrust Banks	Lower Target	Hold	$300.00	Medium
4/23/2019	UBS Group	Initiated Coverage	Buy	$294.00	Medium
4/21/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$360.00	Medium
4/17/2019	Barclays	Lower Target	Overweight ➝ Overweight	$338.00 ➝ $316.00	Medium
3/8/2019	Barclays	Set Target	Buy	$338.00	Low
3/8/2019	Credit Suisse Group	Boost Target	Outperform ➝ Outperform	$344.00 ➝ $368.00	Low
1/31/2019	Barclays	Boost Target	Overweight	$330.00	Low
1/31/2019	Credit Suisse Group	Reiterated Rating	Outperform ➝ Outperform	$330.00 ➝ $344.00	Medium
1/31/2019	Stephens	Boost Target	Overweight	$310.00 ➝ $350.00	Medium
1/31/2019	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$318.00 ➝ $346.00	Medium
1/31/2019	Morgan Stanley	Boost Target	Overweight	$372.00 ➝ $391.00	Medium
1/31/2019	SunTrust Banks	Boost Target		$340.00	Medium
1/31/2019	Morgan Stanley	Reiterated Rating	Overweight ➝ Overweight	$372.00 ➝ $391.00	Medium
1/24/2019	Argus	Initiated Coverage	Buy ➝ Buy	$333.00	Low
1/14/2019	Stephens	Initiated Coverage	Overweight	$310.00	Low
1/6/2019	Barclays	Reiterated Rating	Buy	$282.00	Low
1/3/2019	Evercore ISI	Upgrade	In-Line ➝ Outperform	$255.02	High
12/3/2018	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Buy	$305.00 ➝ $330.00	Medium
12/3/2018	Jefferies Financial Group	Boost Target	Positive ➝ Buy	$323.00 ➝ $345.00	High
11/6/2018	Citigroup	Boost Target	Neutral ➝ Neutral	$290.00 ➝ $292.00	Low
11/1/2018	Royal Bank of Canada	Boost Target	Outperform	$318.00	Low
11/1/2018	SunTrust Banks	Boost Target	Hold	$315.00	Low
11/1/2018	Morgan Stanley	Boost Target	Overweight	$368.00 ➝ $372.00	Low
11/1/2018	Credit Suisse Group	Boost Target	Outperform ➝ Outperform	$311.00 ➝ $330.00	Low
11/1/2018	BMO Capital Markets	Boost Target	Outperform ➝ Buy	$300.00 ➝ $310.00	Medium
11/1/2018	Barclays	Reiterated Rating	Overweight ➝ Overweight	$270.00 ➝ $300.00	High
10/25/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$275.00	Low
10/12/2018	Jefferies Financial Group	Reiterated Rating	Buy	$316.00	Low
9/17/2018	Cowen	Initiated Coverage	Outperform	$318.00	Low
9/10/2018	Citigroup	Downgrade	Buy ➝ Neutral	$162.00	High
9/5/2018	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$273.00 ➝ $368.00	Low
9/4/2018	Credit Suisse Group	Boost Target	Outperform	$284.00 ➝ $311.00	Low
7/26/2018	Jefferies Financial Group	Reiterated Rating	Buy	$296.00	Low
7/26/2018	Morgan Stanley	Boost Target	Equal Weight ➝ Equal Weight	$269.00 ➝ $273.00	Low
7/25/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$275.00	High
7/9/2018	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$275.00 ➝ $290.00	High

(Data available from 6/9/2018 forward)

News Sentiment Rating

0.61 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

22 very positive mentions
30 positive mentions
1 negative mentions
1 very negative mentions

Mentions as of

11/11/2022

13 very positive mentions
8 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

12/11/2022

9 very positive mentions
5 positive mentions
0 negative mentions
2 very negative mentions

Mentions as of

1/10/2023

10 very positive mentions
18 positive mentions
3 negative mentions
2 very negative mentions

Mentions as of

2/9/2023

7 very positive mentions
5 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

3/11/2023

26 very positive mentions
22 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

4/10/2023

33 very positive mentions
43 positive mentions
7 negative mentions
0 very negative mentions

Mentions as of

5/10/2023

10 very positive mentions
12 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

6/9/2023

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Today's Range

Now: $470.27

$464.38

$477.24

50 Day Range

MA: $465.00

$441.60

$496.20

52 Week Range

Now: $470.27

$438.56

$549.52

Volume

740,651 shs

Average Volume

1,139,132 shs

Market Capitalization

$111.48 billion

P/E Ratio

18.30

Dividend Yield

1.29%

Beta

0.85

Frequently Asked Questions

What sell-side analysts currently cover shares of Elevance Health?: The following Wall Street sell-side analysts have issued reports on Elevance Health in the last year: 22nd Century Group, Inc., Bank of America Co., Cantor Fitzgerald, Cowen Inc., Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Loop Capital, Mizuho, Morgan Stanley, Royal Bank of Canada, Stephens, StockNews.com, SVB Leerink LLC, TD Cowen, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for ELV.
What is the current price target for Elevance Health?: 15 Wall Street analysts have set twelve-month price targets for Elevance Health in the last year. Their average twelve-month price target is $570.60, suggesting a possible upside of 20.7%. UBS Group AG has the highest price target set, predicting ELV will reach $610.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $547.00 for Elevance Health in the next year.
View the latest price targets for ELV.
What is the current consensus analyst rating for Elevance Health?: Elevance Health currently has 1 hold rating and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ELV will outperform the market and that investors should add to their positions of Elevance Health.
View the latest ratings for ELV.
What other companies compete with Elevance Health?: Other companies that are similar to Elevance Health include Humana, Centene, Medtronic, Intuitive Surgical and Amgen. Learn More about companies similar to Elevance Health.
How do I contact Elevance Health's investor relations team?: Elevance Health's physical mailing address is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. The company's listed phone number is (800) 331-1476 and its investor relations email address is chr[email protected]. The official website for Elevance Health is www.antheminc.com. Learn More about contacing Elevance Health investor relations.

Elevance Health - ELV Stock Price Target and Predictions

Analyst Price Target for ELV

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.61 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Elevance Health?

What is the current price target for Elevance Health?

What is the current consensus analyst rating for Elevance Health?

What other companies compete with Elevance Health?

How do I contact Elevance Health's investor relations team?